Design, synthesis, docking studies and bioactivity evaluation of 1,2,3-triazole eugenol derivatives

Thiago Antonio de Sousa Cutrim,Fernando Fontes Barcelos,Leandra Martins Meireles,Poliana Aparecida Rodrigues Gazolla,Ângela Maria Almeida Lima,Róbson Ricardo Teixeira,Luiza Carvalheira Moreira,Vagner Tebaldi de Queiroz,Luiz Cláudio Almeida Barbosa,Pedro Alves Bezerra Morais,Cláudia Jorge do Nascimento,Jochen Junker,Adilson Vidal Costa,Marcio Fronza,Rodrigo Scherer
DOI: https://doi.org/10.1080/17568919.2024.2385292
Abstract:Aim: The design, synthesis, docking studies and evaluation of the in vitro antifungal and cytotoxic properties of eugenol (EUG) containing 1,2,3-triazole derivatives are reported. Most of the derivatives have not been reported.Materials & methods: The EUG derivatives were synthesized, molecular docked and tested for their antifungal activity.Results: The compounds showed potent antifungal activity against Trichophyton rubrum, associated with dermatophytosis. Compounds 2a and 2i exhibited promising results, with 2a being four-times more potent than EUG. The binding mode prediction was similar to itraconazole in the lanosterol-14-α-demethylase wild-type and G73E mutant binding sites. Additionally, the pharmacokinetic profile prediction suggests good gastrointestinal absorption and potential oral administration.Conclusion: Compound 2a is a promising antifungal agent against dermatophytosis caused by T. rubrum.
What problem does this paper attempt to address?